Icon (ICLR) Share-based Compensation (2009 - 2026)
Icon's (ICLR) quarterly Share-based Compensation came in at $18.5 million in Q2 2026, up 21.02% year-over-year from $15.3 million in Q2 2025, and down 33.07% quarter-over-quarter from $27.6 million in Q1 2026.
Analysis
Icon (ICLR) Share-based Compensation (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Share-based Compensation for 18 consecutive years, with $18.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 21.02% year-over-year to $18.5 million in Q2 2026; TTM through Jun 2026 was $77.4 million, a 262.01% increase from a year earlier, with the FY2025 full-year figure at $59.0 million, up 224.86% from the prior year.
- Share-based Compensation was $18.5 million for Q2 2026 at Icon, down from $27.6 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $44.9 million in Q3 2025 and troughed at -$88.4 million in Q4 2024.
- A 5-year average of $10.2 million and a median of $15.1 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation tumbled 1157.44% in 2024 and soared 244.52% in 2025, its largest moves.
- Over 5 years, Share-based Compensation stood at $14.8 million in 2022, then sank by 43.56% to $8.4 million in 2023, then plunged by 1157.44% to -$88.4 million in 2024, then soared by 84.72% to -$13.5 million in 2025, then jumped by 236.54% to $18.5 million in 2026.
- The last three Share-based Compensation figures came in at $18.5 million (Q2 2026), $27.6 million (Q1 2026), and -$13.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.35 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 18.46 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 19.78 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 12.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 7.60 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 6.25 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 530,728.82 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.46 Mn |
| Mar 31, 2026 | 27.57 Mn |
| Dec 31, 2025 | -13.52 Mn |
| Sep 30, 2025 | 44.92 Mn |
| Jun 30, 2025 | 15.25 Mn |
| Mar 31, 2025 | 12.36 Mn |
| Dec 31, 2024 | -88.44 Mn |
| Sep 30, 2024 | 13.04 Mn |
| Jun 30, 2024 | 14.96 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Dec 31, 2023 | 8.36 Mn |
| Sep 30, 2023 | 15.95 Mn |
| Jun 30, 2023 | 16.60 Mn |
| Mar 31, 2023 | 14.76 Mn |
| Dec 31, 2022 | 14.82 Mn |
| Sep 30, 2022 | 17.52 Mn |
| Jun 30, 2022 | 19.28 Mn |
| Mar 31, 2022 | 18.90 Mn |
| Dec 31, 2021 | 19.05 Mn |
| Sep 30, 2021 | 100.19 Mn |